[1]
Dr Muhammad Imran Ullah et al. 2024. SYSTEMIC AND PULMONARY HEMODYNAMIC EFFECTS OF SGLT2 INHIBITORS IN HEART FAILURE WITH COEXISTING LUNG DISEASE. Journal of Population Therapeutics and Clinical Pharmacology. 31, 11 (Dec. 2024), 2549–2556. DOI:https://doi.org/10.53555/5mf48423.